Inventor · disambiguated record
Robert Mckay
Also filed as: MCKAY ROBERT · MCKAY ROBERT TRENT
43 granted patents·37 pending applications·1,702 citations·filing 1997–2024
98Inventor score
Top patents by PatentIndex Score
80 records- 0198US9617540B2Compounds and methods for modulating gene expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 11, 2017·26 cites·20 claims
- 0298US9045754B2Short antisense compounds with gapmer configurationBHANOT SANJAY·Filed 2007·Granted Jun 2, 2015·56 cites·44 claims
- 0398US6210892B1Alteration of cellular behavior by antisense modulation of mRNA processingISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 3, 2001·358 cites·31 claims
- 0497US8143230B2Compounds and methods for modulating expression of PCSK9BHANOT SANJAY·Filed 2007·Granted Mar 27, 2012·44 cites·46 claims
- 0597US7399853B2Modulation of glucagon receptor expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 15, 2008·105 cites·26 claims
- 0696US5877309AAntisense oligonucleotides against JNKISIS PHARMACEUTICALS INC·Filed 1997·Granted Mar 2, 1999·189 cites·2 claims
- 0795US8188059B2Compounds and methods for modulating expression of GCGRBHANOT SANJAY·Filed 2007·Granted May 29, 2012·22 cites·36 claims
- 0895US7563884B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 21, 2009·67 cites·28 claims
- 0995US6133246AAntisense oligonucleotide compositions and methods for the modulation of JNK proteinsISIS PHARMACEUTICALS INC·Filed 1999·Granted Oct 17, 2000·262 cites·3 claims
- 1093US8586554B2Compounds and methods for modulating expression of PTP1BBHANOT SANJAY·Filed 2007·Granted Nov 19, 2013·13 cites·45 claims
- 1193US5985558AAntisense oligonucleotide compositions and methods for the inibition of c-Jun and c-FosISIS PHARMACEUTICALS INC·Filed 1997·Granted Nov 16, 1999·101 cites·44 claims
- 1292US6809193B2Antisense oligonucleotide compositions and methods for the modulation of JNK proteinsISIS PHARMACEUTICALS INC·Filed 2001·Granted Oct 26, 2004·33 cites·2 claims
- 1392US6284538B1Antisense inhibition of PTEN expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 4, 2001·38 cites·32 claims
- 1491US7884086B2Conjugates for use in hepatocyte free uptake assaysISIS PHARMACEUTICALS INC·Filed 2005·Granted Feb 8, 2011·21 cites·17 claims
- 1591US6136603AAntisense modulation of interleukin-5 signal transductionISIS PHARMACEUTICALS INC·Filed 1999·Granted Oct 24, 2000·72 cites·32 claims
- 1689US6455307B1Antisense modulation of casein kinase 2-alpha prime expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Sep 24, 2002·25 cites·26 claims
- 1788US8372967B2Compounds and methods for modulating expression of GCCRISIS PHARMACEUTICALS INC·Filed 2007·Granted Feb 12, 2013·5 cites·75 claims
- 1888US6602857B1Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 5, 2003·32 cites·72 claims
- 1988US6448079B1Antisense modulation of p38 mitogen activated protein kinase expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 10, 2002·24 cites·13 claims
- 2087US6312900B1Antisense oligonucleotide compositions and methods for the modulation of activating protein 1ISIS PHARMACEUTICALS INC·Filed 1999·Granted Nov 6, 2001·59 cites·34 claims
- 2186US8673871B2Compounds and methods for modulating expression ApoBBHANOT SANJAY·Filed 2007·Granted Mar 18, 2014·4 cites·19 claims
- 2284US8017760B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·4 cites·13 claims
- 2383US8362232B2Compounds and methods for modulating expression of SGLT2ISIS PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·3 cites·46 claims
- 2483US6187545B1Antisense modulation of pepck-cytosolic expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Feb 13, 2001·17 cites·10 claims
- 2582US7807649B2Modulation of forkhead box O1A expressionISIS PHARMACEUTICALS INC·Filed 2007·Granted Oct 5, 2010·4 cites·33 claims
- 2682US6159734AAntisense modulation of peroxisome proliferator-activated receptor gamma expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Dec 12, 2000·16 cites·13 claims
- 2781US7897583B2Compositions and their uses directed to PTPRUISIS PHARMACEUTICALS INC·Filed 2006·Granted Mar 1, 2011·4 cites·36 claims
- 2880US6323029B1Antisense modulation of glycogen synthase kinase 3 beta expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Nov 27, 2001·12 cites·26 claims
- 2979US8227593B2Modulation of forkhead box O1A expressionDOBIE KENNETH W·Filed 2010·Granted Jul 24, 2012·3 cites·19 claims
- 3078US8642753B2Modulation of glucagon receptor expressionFREIER SUSAN M·Filed 2012·Granted Feb 4, 2014·2 cites·20 claims
- 3177US8969316B2Compounds and methods for modulating expression of DGAT2ISIS PHARMACEUTICALS INC·Filed 2012·Granted Mar 3, 2015·1 cites·20 claims
- 3277US7919476B2Modulation of glucagon receptor expressionISIS PHARMACEUTICALS INC·Filed 2007·Granted Apr 5, 2011·2 cites·33 claims
- 3375US6316259B1Antisense inhibition of glycogen synthase kinase 3 alpha expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Nov 13, 2001·7 cites·26 claims
- 3475US6140124AAntisense modulation of P38 mitogen activated protein kinase expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Oct 31, 2000·27 cites·24 claims
- 3572US8076306B2Compositions and their uses directed to hepcidinMONIA BRETT P·Filed 2007·Granted Dec 13, 2011·1 cites·30 claims
- 3670US6221850B1Antisense oligonucleotide compositions and methods for the modulation of JNK proteinsISIS PHARMACEUTICALS INC·Filed 1998·Granted Apr 24, 2001·23 cites·23 claims
- 3768US2015057329A1Compounds and methods for modulating expression apobISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3865US8791083B2Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometryMONIA BRETT P·Filed 2009·Granted Jul 29, 2014·0 cites·21 claims
- 3964US2025366843A1Bioinductive collagen anchor for tissue repairMCKAY ROBERT TRENT·Filed 2024·Application pending·0 cites
- 4063US8580948B2Modulation of forkhead box O1A expressionDOBIE KENNETH W·Filed 2012·Granted Nov 12, 2013·0 cites·20 claims
- 4163US2012208864A1Compounds and methods for modulating expression of gcgrBHANOT SANJAY·Filed 2012·Application pending·0 cites
- 4262US6030837AAntisense inhibition of PEPCK-mitochondrial expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Feb 29, 2000·17 cites·15 claims
- 4361US2003194738A1Antisense oligonucleotide compositions and methods for the modulation of activating protein 1Filed 2003·Application pending·0 cites
- 4458US2014357856A1Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometryISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4558US2006160760A1Modulation of glucocorticoid receptor expressionISIS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 4657US2002039741A1Antisense oligonucleotide compositions and methods for the modulation of activating protein 1Filed 2001·Application pending·0 cites
- 4756US8299041B2Compositions and their uses directed to acetyl-CoA carboxylasesBHANOT SANJAY·Filed 2006·Granted Oct 30, 2012·0 cites·41 claims
- 4856US2005074801A1Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometryFiled 2004·Application pending·0 cites
- 4955US8853178B2Antisense modulation of PTP1B expressionBHANOT SANJAY·Filed 2011·Granted Oct 7, 2014·0 cites·18 claims
- 5055US2006025372A1Antisense modulation of PTP1B expressionBHANOT SANJAY·Filed 2005·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert Mckay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →